CLL and COVID-19: light at the end of the tunnel?
Blood
.
2022 Aug 4;140(5):407-409.
doi: 10.1182/blood.2022017071.
Authors
Lydia Scarfò
1
,
Yair Herishanu
2
Affiliations
1
Università Vita Salute San Raffaele.
2
Tel Aviv Sourasky Medical Center.
PMID:
35925645
PMCID:
PMC9352187
DOI:
10.1182/blood.2022017071
No abstract available
Publication types
Editorial
Comment
MeSH terms
COVID-19*
Humans
Leukemia, Lymphocytic, Chronic, B-Cell* / therapy